EntryPoint Capital »

Miragen Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $224k 10k 21.58
2025-06-30 $185k 13k 13.98
2025-03-31 $185k 14k 13.48
2024-06-30 $73k 5.6k 13.01